Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal adsorption of toxins" refers to the *physical and biochemical processes by which toxins are either bound within the gastrointestinal lumen (preventing systemic absorption) or transported across the GI mucosa into systemic circulation. This process depends on factors such as gut pH, mucosal integrity, binding capacity of the gut contents (e.g., mucin, dietary fiber, pharmaceutical adsorbents), and the presence of specific transporters or receptors. Clinical interventions such as activated charcoal or other inert adsorbents are used to reduce the absorption of toxins in acute poisoning scenarios, but there is no single molecular 'target' for the process itself. Supporting details: - The GI tract absorbs both nutrients and xenobiotics, with absorption dependent on factors such as site, time of contact, molecular properties, and the presence of binding macromolecules like mucin. - Specific transporters (e.g., divalent metal transporters) and structural proteins (tight junctions, mucins) are involved in regulating what does and does not cross into the circulation. - Some toxins exploit physiological uptake pathways, including endocytosis (e.g., botulinum toxin), and binding to specialized receptors may be involved in their transfer from the gut to the bloodstream. - Clinical therapy for toxin ingestion frequently employs non-specific adsorbents (activated charcoal, etc.) to bind toxins in the gut and reduce absorption. Because this entry refers to a *pathway/process* and not a specific, standardized molecular target, it should be flagged as incorrect if intended for molecular target indexing.
Physical adsorption of toxins in the gut, Prevention of systemic absorption, Binding/bulk sequestration in GI lumen
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal adsorption of toxins.